Kothari Shyam S, Dhopeshwarkar Rajesh A, Saxena Anita, Juneja Rajnish
Cardiothoracic Centre, All India Institute of Medical Sciences, Ansari Nagar, New Delhi.
Indian Heart J. 2003 Mar-Apr;55(2):147-51.
The aim of this study was to ascertain the clinical course and prognosis of dilated cardiomyopathy in Indian children.
The records of 82 children with dilated cardiomyopathy (50 males), less than 12 years of age (mean age 2.9+/-3.07 years), were retrospectively reviewed. Clinical variables, laboratory parameters, and serial echocardiograms were analyzed. On a mean follow-up of 25.09 months (range 15 days-118 months), 9 out of 78 patients died (11.5%) (CI: 4.5%-18.5%). Mortality was 25% (6/24) in infants but the actuarial survival was 87% at 5 years in those diagnosed beyond infancy. Serial echocardiograms of 66 patients (80%) were available. Of these, 39 patients (59%) (CI: 47%-70%) improved, 12 (18%) (CI: 9%-27%) deteriorated or died, and 15 (23%) (CI: 13%-33%) remained unchanged during the follow-up. Among the prognostic variables, only age less than 1 year, higher cardiothoracic ratio, and a higher ratio of left ventricular diastolic dimension/posterior wall thickness was associated with a poor outcome on univariate analysis.
Dilated cardiomyopathy in children pursues a heterogeneous course with a high mortality in infants. A large number of children diagnosed beyond infancy improve or recover. Further characterization of prognostic variables is warranted.
本研究的目的是确定印度儿童扩张型心肌病的临床病程和预后。
回顾性分析了82例年龄小于12岁(平均年龄2.9±3.07岁)的扩张型心肌病患儿(50例男性)的病历。分析了临床变量、实验室参数和系列超声心动图。平均随访25.09个月(范围15天至118个月),78例患者中有9例死亡(11.5%)(可信区间:4.5%-18.5%)。婴儿死亡率为25%(6/24),但婴儿期后确诊的患者5年实际生存率为87%。66例患者(80%)有系列超声心动图资料。其中,39例患者(59%)(可信区间:47%-70%)病情改善,12例(18%)(可信区间:9%-27%)病情恶化或死亡,15例(23%)(可信区间:13%-33%)在随访期间病情无变化。在预后变量中,单因素分析显示只有年龄小于1岁、心胸比高以及左心室舒张内径/后壁厚度比高与不良预后相关。
儿童扩张型心肌病病程各异,婴儿死亡率高。大量婴儿期后确诊的儿童病情改善或康复。有必要进一步明确预后变量。